Skip to content

Clinical trials

Phase 3 Lymphedema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphedema Phase: Phase 3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20071
20131
20182
20192
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Task Force for Global Health3
Gynecologic Oncology Group2
Ontario Clinical Oncology Group (OCOG)2
Memorial Sloan Kettering Cancer Center1
National Cancer Center, Korea1
Trans Tasman Radiation Oncology Group1
University of Wisconsin, Madison1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphedema11
Breast Neoplasms4
Elephantiasis, Filarial3
Filariasis3
Vulvar Neoplasms2
Breast Cancer Lymphedema1
Melanoma1
Postoperative Complications1
Surgical Wound Infection1
Uterine Cervical Dysplasia1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.